0000904454-14-000418.txt : 20140507 0000904454-14-000418.hdr.sgml : 20140507 20140507150718 ACCESSION NUMBER: 0000904454-14-000418 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140507 FILED AS OF DATE: 20140507 DATE AS OF CHANGE: 20140507 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aldeyra Therapeutics, Inc. CENTRAL INDEX KEY: 0001341235 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 617-513-9882 MAIL ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 FORMER COMPANY: FORMER CONFORMED NAME: Aldexa Therapeutics, Inc. DATE OF NAME CHANGE: 20130102 FORMER COMPANY: FORMER CONFORMED NAME: Neuron Systems Inc DATE OF NAME CHANGE: 20051012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TREU JESSE I CENTRAL INDEX KEY: 0001013425 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36332 FILM NUMBER: 14820588 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2014-05-07 0001341235 Aldeyra Therapeutics, Inc. ALDX 0001013425 TREU JESSE I C/O DOMAIN ASSOCIATES, LLC ONE PALMER SQUARE PRINCETON NJ 08542 1 0 1 0 Stock Option (right to buy) 8.00 2014-05-07 4 A 0 12166 0 A 2024-05-06 Common Stock 12166 12166 D The option is exercisable in equal annual installments over three years of the Reporting Person's continuous service to the Issuer after May 7, 2014, the closing date of the Issuer's initial public offering. Kathleen K. Schoemaker, Attorney-in-Fact 2014-05-07